Alpine Immune Sciences Inc
ALPN
ALPN was delisted on the 17th of May, 2024.
23 hedge funds and large institutions have $59.9M invested in Alpine Immune Sciences Inc in 2019 Q1 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 8 reducing their positions, and 3 closing their positions.
119% more capital invested
Capital invested by funds: $27.4M → $59.9M (+$32.5M)
0% more funds holding
Funds holding: 23 → 23 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 3
13% less repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 8
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BI
BVF Inc
San Francisco,
California
|
+$3.48M |
| 2 |
FM
Frazier Management
Seattle,
Washington
|
+$2.32M |
| 3 |
O
OrbiMed
New York
|
+$2.32M |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
+$85.7K |
| 5 |
Northern Trust
Chicago,
Illinois
|
+$64.6K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TM
Tiger Management
New York
|
-$156K |
| 2 |
DS
DRW Securities
Chicago,
Illinois
|
-$117K |
| 3 |
TRCT
Tower Research Capital (TRC)
New York
|
-$14.7K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
-$13K |
| 5 |
Victory Capital Management
San Antonio,
Texas
|
-$9.54K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
26
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| – | -$1K | -405 | Closed |
|
ALPN Hedge Fund Activity: Q1 2019 in Review
23 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Alpine Immune Sciences Inc (ALPN) for Q1 2019, worth a combined $59.9M — up 119% from $27.4M a quarter earlier.
Fund positioning in ALPN was balanced in Q1 2019: 3 funds opened new positions, 3 closed out, 7 added to existing stakes and 8 trimmed.
The largest buyer was BVF Inc, adding an estimated $3.48M. The largest seller was Tiger Management, cutting an estimated $156K.
- 23 institutional investors held Alpine Immune Sciences Inc (ALPN) as of Q1 2019, unchanged from Q4 2018.
- Funds reported $59.9M of Alpine Immune Sciences Inc stock for Q1 2019, up 119% quarter-over-quarter.
- 3 funds opened new Alpine Immune Sciences Inc positions in Q1 2019 and 3 closed out, a net change of 0 holders.
- The largest Alpine Immune Sciences Inc buyer in Q1 2019 was BVF Inc, an estimated $3.48M added.
- The largest Alpine Immune Sciences Inc seller in Q1 2019 was Tiger Management, an estimated $156K sold.
Based on aggregated 13F filings for Q1 2019.